Transcriptome-guided identification of NR4A3 as a candidate gene linking gut microbiota and sensorineural hearing loss
Abstract
Sensorineural hearing loss (SNHL) is a prevalent auditory disorder, with noise exposure being its primary etiological factor; however, its molecular mechanisms and therapeutic targets remain poorly understood. This study integrated multi-omics data and employed weighted gene co-expression network analysis (WGCNA), temporal analysis, Mendelian randomization, molecular docking, and immune infiltration analysis to identify core target genes and investigate their associations with gut microbiota. Two core candidate genes (FOS and NR4A3) were identified through stepwise screening. Mendelian randomization analysis revealed that NR4A3 was negatively associated with the abundance of Lachnospiraceae_NK4A136_group (OR < 1, P < 0.05), a gut microbe with potential protective effects. Immune infiltration analysis revealed significantly increased infiltration levels of regulatory T cells, dendritic cells, and plasma cells in the noise-exposed group, which correlated positively with FOS and NR4A3 expression. Molecular docking and molecular dynamics simulations further suggested that dexamethasone, a compound with potential binding affinity for NR4A3 predicted by computational docking, forms a stable complex with NR4A3. In vitro CCK-8 assays demonstrated that NR4A3 knockdown significantly attenuated cisplatin-induced cytotoxicity in both HEI-OC1 and UB-OC1 auditory cell lines, indicating that NR4A3 functions as a pro-damage factor. Furthermore, treatment with heat-inactivated Lachnospiraceae_NK4A136_group partially alleviated cisplatin-induced cell death, whereas this protective effect was largely abrogated upon NR4A3 knockdown, suggesting that the otoprotective effect of this bacterium is dependent on NR4A3. Collectively, these findings suggest that NR4A3 may contribute to the pathogenesis of SNHL through both direct cellular damage and indirect suppression of protective gut microbiota, thereby representing a candidate gene warranting further investigation for disease intervention.